Pathology and Laboratory Medicine - part 2 pps
Pathology and Laboratory Medicine - part 2 pps
... Chem
20 01;47:464–470.
84. Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk
of coronary artery disease. JAMA 20 01 ;28 6 :21 36 21 42.
32 Aroney and de Lemos
12. Haverkate ... Project. Stroke 20 00;31:
18 02 1811.
24 . Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascular-
ization for cardiogenic shock. JAMA 20...
Pathology and Laboratory Medicine - part 7 pps
... heart dis-
ease: prospective study and updated meta-analyses. Br Med J 20 00; 321 :199 20 4.
12. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reac-
tive protein ... 1987;1:15 27 .
23 . Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensi-
tivity c-reactive protein and lipid screening. Clin Chem 20 01;47 :28 –3...
Pathology and Laboratory Medicine - part 10 pps
... 28 6
CHECKMATE, 25 3
CURE, 21
Disability Angina Pectoris Study,
445
ECAT, 29 2, 29 4, 445
ESCALAT, 78
ESSENCE, 22 , 40, 25 2
EUROCARDI, 326 – 327 , 330
FRISC, 9, 22 , 27 , 40, 46–47, 50, 23 8,
25 2, 29 5, 29 8
FRAXIS, 22
GUARANTEE, ... 339–346
Lp(a), 306
malondialdehyde-modified LDL,
24 8, 25 0, 339–346
myoglobin, 66–69, 75, 20 4, 21 8,
22 3, 22 4, 23 7, 26 5, 26 8,...
PATHOLOGY AND LABORATORY MEDICINE - part 3 ppsx
... infarc-
tion: prognostic value of short- and long-term outcome and predictor of infarct size. Am
Heart J 20 00;140: 126 –133.
1 02. De Sutter J, Van de Wiele C, Gheeraert P, et al. The Selvester 3 2- point ... against doxoru-
bicin toxicity. J Pharmacol Exp Ther 20 00 ;29 1 :29 9–3 02.
35. Al-Shabanah OA, Badary OA, Al-Gharably NM, Al-Sawaf HA. Effects of L-histidinol on
the antitumour...
PATHOLOGY AND LABORATORY MEDICINE - PART 5 pps
... an
assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarc-
tion. Clin Chem 19 92; 38 :22 03 22 14.
45. Ingraham RH, Hodges RS. Effects of Ca
2+
and subunit interactions ... stable part of the molecule and another with antibodies specific to the
amino- (N )- and carboxy- (C)-terminal parts of the molecule, which are very suscepti-
ble to pro...
Pathology and Laboratory Medicine - part 1 pot
... 20 03
616.1 23 075–dc21 20 020 38 720
00/Wu(03 6-0 )/FM/F04 .23 .03 4 /23 /03, 12: 41 PM4
00/Wu(03 6-0 )/FM/F04 .23 .03 4 /23 /03, 12: 42 PM14
2Blomkalns and Gibler
Pathology and Laboratory Medicine
Series Editors: Stewart Sell and ... Cataloging-in-Publication Data
Cardiac markers / edited by Alan H. B. Wu.–2nd ed.
p.;cm.– (Pathology and laboratory medicine)
Includ...
Pathology and Laboratory Medicine - part 4 docx
... resuscitation and cardioversion by
means of combined thallium -2 0 1/technetium-99m pyrophosphate tomography. Eur J Nucl
Med 1995 ;22 : 128 6– 129 1.
50. Grubb NR, Fox KA, Cawood P. Resuscitation from out-of-hospital ... under-
standing of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;
113 :22 7 24 2.
83. Bone RC, Balk RA, Cerra FB, et al. Definitions for seps...
Pathology and Laboratory Medicine - part 6 pptx
... Markers 23 7
Intraindividual biological variance, d
I
2
= d
total-W
2
- d
A
2
Interindividual biological variance, d
G
= d
total-B
2
- d
A
2
- d
I
2
where d
total-W
= total within-subject ... troponin T assay. J Am Coll Cardiol 20 00;1 02( Suppl II): 522 .
22 . Wu AHB, Apple FS. Reporting of cardiac troponin concentration [letter]. Clin Chem 20 02;
48 :20 77 20...
Từ khóa: